Find a Doctor or Practice Location

Medical School: Johns Hopkins University School of Medicine
Residency: Northwestern Medical Center
Residency: New York University Medical Center

American Academy of Dermatology Program for Dermatology for the 21st Century, National American Academy of Dermatology, member, National American College of Physicians, American College of Rheumatology, Canadian Dermatology Society, National Committee on Government and Public Relations. Society of Investigative Dermatology (2002-), Data Safety Monitoring Board for High Dose Immunoblative Cytoxan for Lupus Erythematosus (Michelle Petri, Johns Hopkins), 1999-present, Dermatology Field Advisory Committee,(reports to Central Office, VA), National Dermatology Foundation, Dermatology Study group Co-Chair (1999), FOCIS Abstract Review Committee, National Leaders Society Campaign for the Dermatology Foundation, National Lupus Foundation of America, National Lupus Foundation of Delaware Valley (1998-), Local Lupus Research Institute, Local Medical Advisory Board, Dermatomyositis support group, Arthritis Foundation (Pennsylvania), 2002-, Medical Advisory Board, International Inflammatory Myositis Foundation, International Medical Advisory Board, National Pemphigus Foundation (1997-), National Medical Advisory Board, Scleroderma Foundation, 2002-, National Medical Dermatology Society, Myositis Criteria Study, International National Association of Rheumatologic Dermatology Society, National National Association of VA Dermatologists, National NIH Autoimmune Centers of Excellence, National NIH Meeting on Pemphigus, National NIH/NIAMS Study Section (AMS), National Pennsylvania Academy of Dermatology, Philadelphia College of Physicians, Philadelphia Dermatology Society, Local Skin Rheumatism and Autoimmunity, International Society of Investigative Dermatology, National Society of Investigative Dermatology, National Symposium on Scoring Systems in Dermatology, World Congress of Dermatology, International

Hospital Privileges:

• Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
• Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Description of Research Expertise:

Photobiology
Tumor necrosis factor
Cutaneous lupus
Glycosaminoglycans
Clinical and translational research in cutaneous autoimmune diseases

Selected Publications:

Weinstock MA, Thwin SS, Siegel, JA, …Werth VP, …Huang GD: Chemoprevention of basal and squamous cell carcinoma with a single course of 5-fluorouracil 5% cream: A Veterans Affairs randomized controlled trial JAMA Dermatol 154 (2): 167-174,2018.

Concha JSS, Merola JF, Fiorentino D, Werth VP: Reexamining mechanic’s hands as a characteristic skin finding in dermatomyositis J Am Acad Dermatol 17 (32592-6): 2017.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC: Dermatological Addendum to the 2012 International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheumatol 10 (1002): 2017.

Chansky PB, Olazagasti JM, Feng R, Werth VP.: Cutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) J Am Acad Dermatol 17 (32578): 2017.

Kim HJ, Langenhan JL, Robinson ES, Privette E, Achtman JC, Mitrani RA, Zeidi M, Sharma MR, Feng R, Nevas JL, Calianno C, Okawa J, Taylor L, Pappas-Taffer L, Werth VP.: Effect of Long-term Treatment with TNFα Inhibitors on Single-dose UV-induced Changes in Human Skin. Br J Dermatol doi: 10.1111/bjd.15897 : 2017.

Szczęch J, Samotij D, Werth VP, Reich A: Trigger factors of cutaneous lupus erythematosus: a review of current literature Lupus 26(8) (791-807): 2017.

Pomerantz H, Chren MM, Lew R, Weinstock MA; VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*.: Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial. Clin Exp Dermatol 4295) (488-495): 2017.

Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De la Torre I, Song YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J: International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology... Arthritis Rheumatol 69(5) (898-910): 2017.

van Vollenhoven R., …Werth VP: …Remission in SLE, consensus findings from a large international task force on definitions of remission in SLE (DORIS) Ann Rheum Dis 76 (554-561): 2017.

Werth VP, Fiorentino D, Sullivan BA, Boedigheimer MJ, Chiu K, Wang C, Arnold GE, Damore MA, Bigler J, Welcher AA, Russell CB, Martin DA, Chung JB: Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus Erythematosus Arthritis Rheumatol 69 (1028-1034): 2017.

The Myositis Association

Penn Dermatology website